Literature DB >> 17039400

Oligodendroglioma with neurocytic differentiation versus atypical extraventricular neurocytoma: a case report of unusual pathologic findings of a spinal cord tumor.

Addisalem T Makuria1, Fraser C Henderson, Elisabeth J Rushing, Dan-Paul Hartmann, Norio Azumi, Metin Ozdemirli.   

Abstract

Differentiating oligodendroglioma from extraventricular neurocytoma by conventional light microscopy alone can present a diagnostic challenge. We report pathologic findings of an unusual spinal cord tumor from a 33-year-old male patient which showed hybrid features of oligodendroglioma and extraventricular neurocytoma. Magnetic resonance imaging (MRI) showed an enhancing intramedullary mass in the cervicothoracic region (C7 through T6). Histologic examination revealed a clear cell neoplasm containing ganglion-like cells and calcifications, prompting the differential diagnosis of oligodendroglioma and extraventricular neurocytoma. The immunohistochemical analysis disclosed neural differentiation of the neoplastic cells with strong synaptophysin and neurofilament staining consistent with extraventricular neurocytoma, as well as strong S-100 and glial fibrillary acidic protein (GFAP) expression. Molecular studies with fluorescent in situ hybridization (FISH) revealed chromosome 1p/(partial) 19q deletions, a finding commonly observed in oligodendroglioma. The proliferation index (using antibody MIB1) of the tumor was approximately 30%. The morphologic findings and these results strengthen the hypothesis that these tumors may share a common progenitor cell, which has also been observed by others. Because there are differences in patient management and long-term prognosis, it is important to attempt to distinguish between oligodendroglioma and neurocytoma. This unusual case and similar rare reported cases support the need to reclassify tumors showing pathologic features common to both neurocytoma and oligodendroglioma as a unique entity, while the effort continues to identify the cell of origin.

Entities:  

Mesh:

Year:  2006        PMID: 17039400     DOI: 10.1007/s11060-006-9268-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

1.  Atypical extraventricular neurocytoma.

Authors:  Sayaka Moriguchi; Atsushi Yamashita; Kousuke Marutsuka; Takumi Yoneyama; Shinichi Nakano; Shinichiro Wakisaka; Kazuki Nabeshima; Yujiro Asada
Journal:  Pathol Int       Date:  2006-01       Impact factor: 2.534

2.  Tissue culture of human neurocytomas induces the expression of glial fibrilary acidic protein.

Authors:  M Westphal; H Meissner; J Matschke; H D Herrmann
Journal:  J Neurocytol       Date:  1998-11

3.  Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies.

Authors:  A von Deimling; R Janzer; P Kleihues; O D Wiestler
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome.

Authors:  I R Mackenzie
Journal:  Cancer       Date:  1999-04-01       Impact factor: 6.860

5.  Intraventricular neurocytoma: clinicopathological analysis of seven cases.

Authors:  D G Kim; J G Chi; S H Park; K H Chang; S H Lee; H W Jung; H J Kim; B K Cho; K S Choi; D H Han
Journal:  J Neurosurg       Date:  1992-05       Impact factor: 5.115

6.  In vitro identification and functional characterization of glial precursor cells in human gliomas.

Authors:  C Colin; N Baeza; S Tong; C Bouvier; B Quilichini; P Durbec; D Figarella-Branger
Journal:  Neuropathol Appl Neurobiol       Date:  2006-04       Impact factor: 8.090

7.  Primary neurocytoma of the spinal cord: a case report and review of literature.

Authors:  Suash Sharma; Chitra Sarkar; Shailesh Gaikwad; Ashish Suri; Mehar C Sharma
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

8.  Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study.

Authors:  S B Wharton; K K Chan; F A Hamilton; J R Anderson
Journal:  Neuropathol Appl Neurobiol       Date:  1998-08       Impact factor: 8.090

9.  Atypical extraventricular neurocytoma with oligodendroglioma-like spread and an unusual pattern of chromosome 1p and 19q loss.

Authors:  Robert E Mrak; M Gazi Yasargil; Gayatry Mohapatra; James Earel; David N Louis
Journal:  Hum Pathol       Date:  2004-09       Impact factor: 3.466

10.  Neurocytoma of spinal cord.

Authors:  S Coca; M Moreno; J A Martos; J Rodriguez; A Barcena; J Vaquero
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  6 in total

1.  Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.

Authors:  Fulin Wang; Guangyu Qiao; Xin Lou
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

2.  Expression of KIAA 0864 protein in neuroepithelial tumors: an analysis based on the presence of monoclonal antibody HFB-16.

Authors:  Yasuo Sugita; Yasuhiro Nakamura; Munehiko Yamamoto; Sachiko Ogasawara; Kouichi Ohshima; Minoru Shigemori
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

Review 3.  Ganglioneurocytoma of the spinal cord: report of a case and review of literature.

Authors:  Gianluca Marucci; Andrea Barbanera; Elena Serchi; Alvaro Andreoli
Journal:  Eur Spine J       Date:  2008-09-24       Impact factor: 3.134

4.  Something old and something new about molecular diagnostics in gliomas.

Authors:  Craig Horbinski
Journal:  Surg Pathol Clin       Date:  2012-12-01

5.  Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.

Authors:  Arie Perry; Stephanie S Burton; Gregory N Fuller; Christopher A Robinson; Cheryl A Palmer; Lothar Resch; Eileen H Bigio; Meena Gujrati; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

6.  Differential hypermethylation of death-associated protein kinase promoter in central neurocytoma and oligodendroglioma.

Authors:  Chia-Li Chung; Hung Pei Tsai; Cheng-Yu Tsai; Wan-Tzu Chen; Ann-Shung Lieu; Chih-Jen Wang; Jason Sheehan; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Biomed Res Int       Date:  2014-04-27       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.